Unlocking the role of EIF5A: A potential diagnostic marker regulating the cell cycle and showing negative correlation with immune infiltration in lung adenocarcinoma.

MLA

Yang, Zipeng, et al. “Unlocking the Role of EIF5A: A Potential Diagnostic Marker Regulating the Cell Cycle and Showing Negative Correlation with Immune Infiltration in Lung Adenocarcinoma.” International Immunopharmacology, vol. 126, Jan. 2024, p. 111227. EBSCOhost, https://doi.org/10.1016/j.intimp.2023.111227.

APA

Yang, Z., Yuan, H., He, H., Qi, S., Zhu, X., Hu, X., Jin, M., Zhang, X.-X., & Yuan, Z.-G. (2024). Unlocking the role of EIF5A: A potential diagnostic marker regulating the cell cycle and showing negative correlation with immune infiltration in lung adenocarcinoma. International Immunopharmacology, 126, 111227. https://doi.org/10.1016/j.intimp.2023.111227

Chicago

Yang, Zipeng, Hao Yuan, Houjing He, Shuting Qi, Xiaojing Zhu, Xiaoyu Hu, Mengyuan Jin, Xiu-Xiang Zhang, and Zi-Guo Yuan. 2024. “Unlocking the Role of EIF5A: A Potential Diagnostic Marker Regulating the Cell Cycle and Showing Negative Correlation with Immune Infiltration in Lung Adenocarcinoma.” International Immunopharmacology 126 (January): 111227. doi:10.1016/j.intimp.2023.111227.